Dyadic Netherlands to develop baking enzymes for EU-funded research project
Dyadic International Inc., Jupiter, Fla., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the industrial enzyme, bioenergy, bio-based chemical and biopharmaceutical industries, has announced that its research and development center in Wageningen, Netherlands, is a participant in the HealthBread Project, a new multidisciplinary research program that has been awarded approximately 1 million euros from the European Community’s Seventh Framework Programme (FP7).
The HealthBread Project is a two-year research program whose objective is to develop whole-grain and white breads with improved nutritional value, taste and product quality by applying scientific and technological knowledge to the production and marketing of commercially viable, healthier bread. Dyadic Netherlands will receive approximately 143,000 euros to develop commercial enzymes for the HealthBread Project, which is scheduled to begin in October 2012.